Clinical Trial Update: Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study of Bortezomib with antiviral therapy followed by effusion drainage, Bevacizumab, and combination chemotherapy for primary effusion lymphoma has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Effusion Lymphoma
• Lymphoma

Drugs mentioned

• Antiviral therapy
• Bevacizumab (bevacizumab)
• Bortezomib (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 2 | Status: COMPLETED